Found 20 matching trials
A Study to Test Once-Weekly Doses of Odanacatib (MK0822) on Healthy Adult Females (0822-005)(COMPLETED) PHASE1 This study will assess the safety, tolerability, PK, and PD of a once weekl...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050) PHASE3 This study will evaluate the therapeutic effects and safety of odanacatib o...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Multiple Oral Doses of Odanacatib (MK0822) in Healthy Adults (0822-002) PHASE1 This study will assess the safety, tolerability, pharmacokinetics, and phar...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED) PHASE2 This is a 4-week study to examine the effects of a new experimental medicat...
Show More Location
Multiple Locations
Learn More & Join Trial
Assessment of Pharmacokinetics of Single Dose Odanacatib (MK-0822) in Participants With Moderate Hepatic Insufficiency (MK-0822-070) PHASE1 This open-label, non-randomized study was designed to compare pharmacokinet...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Tolerability of Odanacatib (0822-059) PHASE1 This study will test the weighted average inhibition of u-NTx/Cre (aminoter...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018) PHASE3 The purpose of the event-driven base study is to determine the safety and e...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Evaluate Efficacy of Odanacatib (MK-0822) on Bone Mineral Density (BMD) and Bone Micro-architecture and Overall Safety in Postmenopausal Women (MK-0822-031) PHASE3 This study will evaluate the safety and treatment effect of 50 mg odanacati...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Assess the Effects of a Light Breakfast on the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) PHASE1 This study will assess the safety and tolerability of single doses of odana...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Assess Safety and Efficacy of Odanacatib (MK-0822) in Men With Osteoporosis (MK-0822-053) PHASE3 The purpose of this study is to test the hypothesis that treatment with oda...
Show More Location
Multiple Locations
Learn More & Join Trial